Related Experiment Video
Updated: Jul 22, 2025

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
The impact of the apelinergic system in coronary collateral formation
İbrahim Özsoyler1, Haci Ali Uçak1, Tolga Onur Badak1
1Department of Cardiovascular Surgery, Health Sciences University, Adana Şehir Training and Research Hospital, Adana, Türkiye.
Insights
Serum elabela levels are linked to good coronary collateral circulation. Higher elabela indicates better collateral development, suggesting its potential as a therapeutic target for cardiovascular health.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
Background:
- Coronary artery disease (CAD) impacts millions globally.
- Coronary collateral circulation (CCC) is a critical compensatory mechanism in CAD.
- Understanding factors influencing CCC development is vital for patient outcomes.
Purpose of the Study:
- To investigate the association between serum elabela levels and the development of CCC in patients with CAD.
- To determine if elabela can serve as a predictive marker for CCC status.
Main Methods:
- Cross-sectional study involving 150 participants (50 controls, 100 CAD patients) from January 2020 to December 2021.
- Patients with CAD were stratified into groups with poor and good CCC based on Rentrop classification.
- Serum elabela levels were measured and compared across all groups.
Main Results:
- Serum elabela levels were significantly higher in patients with good CCC compared to those with poor CCC and controls (p<0.05).
- Low serum elabela levels were associated with a 2.43-fold increased risk of developing poor CCC.
Conclusions:
- The elabela protein is directly correlated with favorable collateral development in the coronary arteries.
- Elabela shows potential as a therapeutic agent to promote collateral growth and improve outcomes in CAD patients.
Background:
This study aims to examine the relationship between the development of coronary collateral circulation and serum elabela levels.
Methods:
Between January 2020 and December 2021, a total of 50 control individuals (29 males, 21 females; mean age: 63.2±10.0 years; range, 52 to 73 years) with no significant coronary artery disease as confirmed by angiography (Group 1) and 100 patients (55 males, 45 females; mean age: 66.6±9.6 years; range, 56 to 75 years) with coronary artery disease were included. The patients were further divided into two equal groups according to the Rentrop classification as poor (Group 2) and good coronary collateral circulation (Group 3). All groups were compared in terms of several parameters, particularly serum elabela levels.
Results:
Serum elabela levels were found to be statistically higher in the group with good collateral than the other groups (p<0.05). Low serum elabela levels increased the risk of developing weak collaterals by 2.43 times.
Conclusion:
The elabela protein is directly related to good collateral development and can be considered a potential agent for treatment.
More Related Videos
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
Intracellular Signaling Affects Focal Adhesions
Some...
Peripheral Artery Disease I: Introduction

